TERESA SCANLAN: Open Payments
NPI 1558870329 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 10 payments from 5 companies in 2025. Trend: 2023 $568 · 2024 $528 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| CVRx, Inc. | 1 | $9 |
Products named: REPATHA, LEQVIO, FARXIGA, VYNDAQEL, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
